Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 CAD | -.--% |
|
-.--% | -60.00% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gadi Levin
CEO | Chief Executive Officer | 52 | 01/16/01 |
Alan Rootenberg
DFI | Director of Finance/CFO | 72 | 31/23/31 |
Terry F. Plasse
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ari Kellen
BRD | Director/Board Member | - | 05/17/05 |
Gadi Levin
CEO | Chief Executive Officer | 52 | 01/16/01 |
Shawn Langer
BRD | Director/Board Member | - | 05/17/05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 136,978,973 | 125,794,590 ( 91.83 %) | 0 | 91.83 % |
Company contact information
![address Vaxil Bio Ltd.(VXL)](https://cdn.zonebourse.com/static/address/49478378.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-60.00% | 1M | |
+20.63% | 127B | |
+25.41% | 27.67B | |
-20.17% | 20.33B | |
-16.61% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+58.32% | 14.43B | |
+149.98% | 12.49B |
- Stock Market
- Equities
- VXL Stock
- Company Vaxil Bio Ltd.